RMC
PBYI icon

Resources Management Corp’s Puma Biotechnology PBYI Stock Holding History

Resources Management Corp’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$32K Sell
1,615
-600
-27% -$18K 0.01% 315
2018
Q3 		$101K Buy
+2,215
New +$107K 0.02% 240

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Resources Management Corp's PBYI Position: Q4 2018 in Review

Resources Management Corp reduced its Puma Biotechnology (PBYI) stake by 27% in Q4 2018, selling an estimated $18K and leaving 1,615 shares worth $32K. The position accounts for 0.01% of the portfolio, ranked #315.

Resources Management Corp first reported a position in PBYI in Q3 2018 and has held it in 2 quarters since. The position peaked at $101K in Q3 2018. 141 funds tracked by Wall St. Rank hold PBYI as of Q4 2018.

  • Resources Management Corp held 1,615 shares of Puma Biotechnology worth $32K as of Q4 2018.
  • Resources Management Corp sold 600 Puma Biotechnology shares in Q4 2018, an estimated $18K.
  • Puma Biotechnology made up 0.01% of Resources Management Corp's portfolio in Q4 2018, its #315 holding.
  • Resources Management Corp first reported a position in Puma Biotechnology in Q3 2018 and has held it in 2 quarters since.
  • Resources Management Corp's Puma Biotechnology position peaked at $101K in Q3 2018.
  • 141 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2018.

Based on Resources Management Corp's 13F filing for Q4 2018, filed 21 Feb 2019.